POSTER: MCL-096 Lisocabtagene Maraleucel (Liso-Cel) in R/R MCL: Primary Analysis Results From the MCL Cohort of the Single-Arm, Multicenter, Phase I Seamless Design TRANSCEND NHL 001 Study

Clinical Lymphoma, Myeloma & Leukemia(2023)

引用 0|浏览5
暂无评分
关键词
MCL,mantle cell lymphoma,lisocabtagene maraleucel,relapsed or refractory,CAR T-cell therapy,Phase I
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要